Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them.
- Where Trial Budgets And Supply Plans Go Off Track — Earlier Than You Think
- From Policy To Practice: Embedding Export Compliance In Clinical Supply
- What CAPAs Don't Catch: 3 Hidden ATMP Cold Chain Vulnerabilities By Design
- AI And Digital Tools Advance Clinical Trial Supply Chains
- Solving Pharmacy And Clinical Supply Challenges In Decentralized Trials
- How The Strait Of Hormuz Crisis Is Stalling U.S. Medical Breakthroughs
- The Hidden Bottleneck: Clinical Supply Strategy In Study Start-Up
- Why More Tools Won't Fix Clinical Supply
ON-DEMAND WEBINARS
Clinical supply innovators from across the industry share their experiences and lessons learned as they work to normalize the use of adherence measurement tools and smart medicine packages.
Learn how to synthesize individual symptomatic data into a comprehensive narrative of tolerability, ultimately enhancing the clinical value and regulatory positioning of your oncology assets.
Gain insights into managing global trial complexity, balancing accelerated timelines with compliance, using advanced technologies to improve efficiency, and leveraging partnerships to support seamless clinical operations.
Learn how leveraging a customs warehouse can streamline your supply chain, reduce VAT costs, and enhance global compliance and efficiency.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-2151295139-computer-hands-technology]( "Web-Based CDR System: Precision Without Compromise")
Web-Based CDR System: Precision Without CompromiseValidated research confirms that web-based cognitive testing maintains the millisecond precision of traditional hardware, ensuring high-quality data for decentralized clinical trials.
-
![GettyImages-2169608710-blister-packaging-pill-nutraceutical]( "Rare Diseases And The Integrated CDMO Support System")
Rare Diseases And The Integrated CDMO Support SystemChampion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
![GettyImages-1616837193 coworkers tablet]( "How A Biotech Startup Transformed Their Clinical Trial Supply Management")
How A Biotech Startup Transformed Their Clinical Trial Supply ManagementDon’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.
-
![cell-gene-therapy-GettyImages-2157300524]( "FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study")
FastChain®: A Solution For Made-To-Order Gene Replacement Therapy StudyAdopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.
-
![Europe Globe Map Data GettyImages REV-1319209608]( "How Regional Logistics Strategy Supports Clinical Success In Europe")
How Regional Logistics Strategy Supports Clinical Success In EuropeIn an era where trial delays, customs bottlenecks, and fragmented regulations can derail even the most promising program, logistics has become a strategic asset.
-
![GettyImages-1572384472 recall, packaging, shipping]( "Risk Mitigation Planning For Pharmaceutical Tariffs")
Risk Mitigation Planning For Pharmaceutical TariffsExamine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability.
-
![iStock-1277730987-supply-chain-logistics-tracking-sourcing]( "Industry Trends: Clinical Logistics Outsourcing")
Industry Trends: Clinical Logistics OutsourcingUnderstanding industry trends, market dynamics, and the selection criteria decision-makers apply when choosing a clinical logistics service provider informs and contextualizes outsourcing decisions.
-
![Pharmaceutical-Drug-Manufacturing-GettyImages-1405788565]( "Specializing In Small And Early-Stage Partners, Not Just Small Batches")
Specializing In Small And Early-Stage Partners, Not Just Small BatchesMany small and/or early-stage companies are not aware of the need, or the possibility, of finding a CDMO that specializes in meeting their specific requirements.
-
![GettyImages-527547688 spreadsheet]( "Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting")
Transforming Clinical Supply Planning From Spreadsheets To Smart ForecastingStreamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.
-
![Pharma Manufacturing GettyImages-1135140594]( "Outsourcing Your Highly Potent Oncology Drug Product")
Outsourcing Your Highly Potent Oncology Drug ProductPrecision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
